[ { "@id": "http://purl.org/np/RAPrl16L80CIV3rcdxFwwW4hZVuMKrbnrj_vPFgg9Dzy0#provenance", "@graph": [ { "@id": "http://purl.org/np/RAPrl16L80CIV3rcdxFwwW4hZVuMKrbnrj_vPFgg9Dzy0#assertion", "http://www.w3.org/ns/prov#generatedAtTime": [ { "@value": "2021-07-25T21:47:40.361459", "@type": "http://www.w3.org/2001/XMLSchema#dateTime" } ] } ] }, { "@id": "http://purl.org/np/RAPrl16L80CIV3rcdxFwwW4hZVuMKrbnrj_vPFgg9Dzy0#pubInfo", "@graph": [ { "@id": "http://purl.org/np/RAPrl16L80CIV3rcdxFwwW4hZVuMKrbnrj_vPFgg9Dzy0#sig", "http://purl.org/nanopub/x/hasAlgorithm": [ { "@value": "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey": [ { "@value": "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature": [ { "@value": "cNcX3RSgSXaBGY4tnz3wWzdnOI6Whvgiq7oGY0cuhGAof+zRK6lG0i4+vrhOn9sbGm95z9Hv41xK5nclF580+ol/vdW00gaf8arkKF2MTF1FhBxkgOZl2PG0f0o0hPpDCdxuQc8KCPoKFjU8YYIjrWWygbxXGe2zLzE7imp13YM=" } ], "http://purl.org/nanopub/x/hasSignatureTarget": [ { "@id": "http://purl.org/np/RAPrl16L80CIV3rcdxFwwW4hZVuMKrbnrj_vPFgg9Dzy0" } ] }, { "@id": "http://purl.org/np/RAPrl16L80CIV3rcdxFwwW4hZVuMKrbnrj_vPFgg9Dzy0", "http://www.w3.org/ns/prov#generatedAtTime": [ { "@value": "2021-07-25T21:47:40.361459", "@type": "http://www.w3.org/2001/XMLSchema#dateTime" } ], "http://www.w3.org/ns/prov#wasAttributedTo": [ { "@id": "https://orcid.org/0000-0002-8954-0470" } ] } ] }, { "@id": "http://purl.org/np/RAPrl16L80CIV3rcdxFwwW4hZVuMKrbnrj_vPFgg9Dzy0#assertion", "@graph": [ { "@id": "http://purl.org/np/RAPrl16L80CIV3rcdxFwwW4hZVuMKrbnrj_vPFgg9Dzy0#assertion", "http://www.w3.org/ns/prov#wasGeneratedBy": [ { "@value": "S&T TWOC project version 1" } ] }, { "@id": "http://purl.org/np/RAPrl16L80CIV3rcdxFwwW4hZVuMKrbnrj_vPFgg9Dzy0#version", "http://www.w3.org/ns/prov#value": [ { "@value": "1", "@type": "http://www.w3.org/2001/XMLSchema#integer" } ] }, { "@id": "http://www.w3.org/1999/02/22-rdf-syntax-ns#object", "https://uts.nlm.nih.gov/uts/umls/concept/C0086582": [ { "@value": "male" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C0439234": [ { "@value": "years" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C1706180": [ { "@value": "male" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C1706428": [ { "@value": "male" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C1706429": [ { "@value": "male" } ] }, { "@id": "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate", "http://twoc-nlp-database-server-1:8555/solr/predicates/select?q=TRIPLE_UID:39u835ce-TRIPLE-ABSTRACT-17": [ { "@value": "be" } ] }, { "@id": "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject", "https://uts.nlm.nih.gov/uts/umls/concept/C0011777": [ { "@value": "dexamethasone" } ] }, { "@id": "http://www.w3.org/2000/01/rdf-schema#Triple-UID", "http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:39u835ce-TRIPLE-ABSTRACT-17": [ { "@value": "39u835ce-TRIPLE-ABSTRACT-17" } ] }, { "@id": "http://www.w3.org/2000/01/rdf-schema#sentence", "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "A clinical interpretation of the Randomized Evaluation of COVID-19 Therapy (RECOVERY) study was performed to provide a useful tool to understand whether, when, and to whom dexamethasone should be administered during hospitalization for COVID-19 A post hoc analysis of data published in the preliminary report of the Randomized Evaluation of COVID-19 Therapy (RECOVERY) study was performed to calculate the person-based number needed to treat (NNT) and number needed to harm (NNH) of 6 mg dexamethasone once daily for up to 10 days vs usual care with respect to mortality At day 28, the NNT of dexamethasone vs usual care was 36 0 (95%CI 24 9–65 1, p <0 05) in all patients, 8 3 (95%CI 6 0–13 1, p <0 05) in patients receiving invasive mechanical ventilation, and 34 6 (95%CI 22 1–79 0, p <0 05) in patients receiving oxygen only (with or without noninvasive ventilation) dexamethasone increased mortality compared with usual care in patients not requiring oxygen supplementation, leading to a NNH value of 26 7 (95%CI 18 1–50 9, p <0 05) NNT of dexamethasone vs usual care was 17 3 (95%CI 14 9–20 6) in subjects <70 years, 27 0 (95%CI 18 5–49 8) in men, and 16 2 (95%CI 13 2–20 8) in patients in which the onset of symptoms was >7 days dexamethasone is effective in male subjects <70 years that require invasive mechanical ventilation experiencing symptoms from >7 days and those patients receiving oxygen without invasive mechanical ventilation;it should be avoided in patients not requiring respiratory support" } ] }, { "@id": "http://www.w3.org/2000/01/rdf-schema#triple", "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "dexamethasone is in male subjects & lt;70 years" } ] } ] }, { "@id": "http://purl.org/np/RAPrl16L80CIV3rcdxFwwW4hZVuMKrbnrj_vPFgg9Dzy0#Head", "@graph": [ { "@id": "http://purl.org/np/RAPrl16L80CIV3rcdxFwwW4hZVuMKrbnrj_vPFgg9Dzy0", "http://www.nanopub.org/nschema#hasAssertion": [ { "@id": "http://purl.org/np/RAPrl16L80CIV3rcdxFwwW4hZVuMKrbnrj_vPFgg9Dzy0#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance": [ { "@id": "http://purl.org/np/RAPrl16L80CIV3rcdxFwwW4hZVuMKrbnrj_vPFgg9Dzy0#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo": [ { "@id": "http://purl.org/np/RAPrl16L80CIV3rcdxFwwW4hZVuMKrbnrj_vPFgg9Dzy0#pubInfo" } ], "@type": [ "http://www.nanopub.org/nschema#Nanopublication" ] } ] } ]